JP2001525816A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001525816A5 JP2001525816A5 JP1998548911A JP54891198A JP2001525816A5 JP 2001525816 A5 JP2001525816 A5 JP 2001525816A5 JP 1998548911 A JP1998548911 A JP 1998548911A JP 54891198 A JP54891198 A JP 54891198A JP 2001525816 A5 JP2001525816 A5 JP 2001525816A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85488197A | 1997-05-12 | 1997-05-12 | |
| US08/854,881 | 1997-05-12 | ||
| PCT/GB1998/001343 WO1998051344A1 (en) | 1997-05-12 | 1998-05-12 | Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001525816A JP2001525816A (ja) | 2001-12-11 |
| JP2001525816A5 true JP2001525816A5 (enExample) | 2005-12-02 |
Family
ID=25319772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54891198A Withdrawn JP2001525816A (ja) | 1997-05-12 | 1998-05-12 | 治療における腫瘍壊死因子アルファおよび血管内皮成長因子の抑制 |
Country Status (6)
| Country | Link |
|---|---|
| EP (2) | EP0980258A1 (enExample) |
| JP (1) | JP2001525816A (enExample) |
| AU (1) | AU7345798A (enExample) |
| CA (1) | CA2290021A1 (enExample) |
| HK (1) | HK1044887A1 (enExample) |
| WO (1) | WO1998051344A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3443119B2 (ja) | 1989-08-07 | 2003-09-02 | ペプテック リミテッド | 腫瘍壊死因子結合リガンド |
| US20030225254A1 (en) | 1989-08-07 | 2003-12-04 | Rathjen Deborah Ann | Tumour necrosis factor binding ligands |
| US7192584B2 (en) | 1991-03-18 | 2007-03-20 | Centocor, Inc. | Methods of treating psoriasis with anti-TNF antibodies |
| EP1049773B1 (en) | 1998-01-22 | 2007-07-25 | Btg International Limited | Inhibition of cytokine production |
| JP2002538170A (ja) * | 1999-03-02 | 2002-11-12 | セントコール， インコーポレイテッド | 喘息の治療における抗−ＴＮＦα抗体 |
| US20040220103A1 (en) | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
| US7446174B2 (en) | 2001-03-02 | 2008-11-04 | Xencor, Inc. | Protein based TNF-α variants for the treatment of TNF-α related disorders |
| US7101974B2 (en) | 2000-03-02 | 2006-09-05 | Xencor | TNF-αvariants |
| US7687461B2 (en) | 2000-03-02 | 2010-03-30 | Xencor, Inc. | Treatment of TNF-α related disorders with TNF-α variant proteins |
| US7244823B2 (en) | 2000-03-02 | 2007-07-17 | Xencor | TNF-alpha variants proteins for the treatment of TNF-alpha related disorders |
| US7662367B2 (en) | 2000-03-02 | 2010-02-16 | Xencor, Inc. | Pharmaceutical compositions for the treatment of TNF-α related disorders |
| US7056695B2 (en) | 2000-03-02 | 2006-06-06 | Xencor | TNF-α variants |
| AU4541101A (en) * | 2000-03-02 | 2001-09-12 | Xencor Inc | Design and discovery of protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| US9028822B2 (en) | 2002-06-28 | 2015-05-12 | Domantis Limited | Antagonists against TNFR1 and methods of use therefor |
| CN101745112A (zh) * | 2002-07-19 | 2010-06-23 | 艾博特生物技术有限公司 | TNFα相关疾病的治疗 |
| MXPA05003889A (es) | 2002-10-15 | 2005-06-22 | Celgene Corp | Farmacos inhibidores de citosina selectiva para tratar sindrome mielodisplastico. |
| US7101978B2 (en) | 2003-01-08 | 2006-09-05 | Applied Molecular Evolution | TNF-α binding molecules |
| JP2007504122A (ja) | 2003-08-29 | 2007-03-01 | ファイザー・インク | 新規抗血管形成剤として有用なチエノピリジン−フェニルアセトアミドおよびその誘導体 |
| WO2005041877A2 (en) * | 2003-10-29 | 2005-05-12 | Children's Medical Center Corporation | Method of inhibiting rejection following organ transplantation |
| AP2006003619A0 (en) | 2003-12-23 | 2006-06-30 | Pfizer | Novel quinoline derivatives |
| US7435799B2 (en) | 2004-01-08 | 2008-10-14 | Applied Molecular Evolution | TNF-α binding molecules |
| BRPI0610058A2 (pt) | 2005-05-16 | 2010-05-25 | Abbott Biotech Ltd | uso de inibidor de tnf para tratamento da poliartrite erosiva |
| JP2008120722A (ja) * | 2006-11-10 | 2008-05-29 | Benesis Corp | 生物由来製品の偽薬 |
| EP2408493B1 (en) | 2009-03-20 | 2024-07-24 | Antares Pharma, Inc. | Hazardous agent injection system |
| CA2832759A1 (en) | 2011-05-06 | 2012-11-15 | Bio-Rad Laboratories, Inc. | Thermal cycler with vapor chamber for rapid temperature changes |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69233701T2 (de) * | 1991-03-18 | 2008-04-10 | New York University | Monoklonale und chimäre Antikörper spezifisch für menschlichen Tumornekrosefaktor |
| JPH07504203A (ja) * | 1992-09-15 | 1995-05-11 | イミュネックス・コーポレーション | 腫瘍壊死因子アンタゴニストを用いるｔｎｆ−依存性炎症の治療方法 |
| US6270766B1 (en) * | 1992-10-08 | 2001-08-07 | The Kennedy Institute Of Rheumatology | Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease |
| EP1238986B1 (en) * | 1992-10-28 | 2008-06-25 | Genentech, Inc. | Use of Vascular endothelial cell growth factor antagonists |
| US7608262B2 (en) * | 1996-02-16 | 2009-10-27 | The Kennedy Institute Of Rheumatology | Methods of preventing or treating thrombosis with tumor necrosis factor antagonists |
-
1998
- 1998-05-12 CA CA002290021A patent/CA2290021A1/en not_active Abandoned
- 1998-05-12 EP EP98920669A patent/EP0980258A1/en not_active Ceased
- 1998-05-12 JP JP54891198A patent/JP2001525816A/ja not_active Withdrawn
- 1998-05-12 AU AU73457/98A patent/AU7345798A/en not_active Abandoned
- 1998-05-12 EP EP01117491A patent/EP1170017A1/en not_active Withdrawn
- 1998-05-12 WO PCT/GB1998/001343 patent/WO1998051344A1/en not_active Ceased
-
2002
- 2002-07-09 HK HK02105101.3A patent/HK1044887A1/en unknown